EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Genomics for antimicrobial resistance—progress and future directions

Norelle L Sherry iD, Jean Y H Lee iD, Stefano G Giulieri iD, Christopher H Connor, Kristy Horan, Jake A Lacey, Courtney R Lane, Glen P Carter, Torsten Seemann, Adrian Egli iD, Timothy P Stinear iD, Benjamin P Howden iD

Antimicrobial Agents and Chemotherapy · 07.05.2025 · 69 (5)

DOI: 10.1128/aac.01082-24 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 07.05.2025. Verfasst von Norelle L Sherry und 11 weiteren Autor:innen. Beteiligte Einrichtung: Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, University of Melbourne at the Doherty Institute…. Hauptthemen laut MEDLINE: Genomics, Anti-Bacterial Agents, Drug Resistance, Bacterial, Bacteria. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance (AMR) is a critical global public health threat, with bacterial pathogens of primary concern. Pathogen genomics has revolutionized the study of bacterial pathogens and provided deep insights into the mechanisms and dissemination of AMR, with the precision of whole-genome sequencing informing better control strategies. However, generating actionable data from genomic surveillance and diagnostic efforts requires integration at the public health and clinical interface that goes beyond academic efforts to identify resistance mechanisms, undertake post hoc analyses of outbreaks, and share data after research publications. In addition to timely genomics data, consideration also needs to be given to epidemiological sampling frames, analysis, and reporting mechanisms that meet International Organization for Standardization (ISO) standards and generation of reports that are interpretable and actionable for public health and clinical “end-users.” Importantly, ensuring all countries have equitable access to data and technology is critical, through timely data sharing following the FAIR principles (findable, accessible, interoperable, and re-usable). In this review, we describe (i) advances in genomic approaches for AMR research and surveillance to understand emergence, evolution, and transmission of AMR and the key requirements to enable this work and (ii) discuss emerging and future applications of genomics at the clinical and public health interface, including barriers to implementation. Harnessing advances in genomics-enhanced AMR research and embedding robust and reproducible workflows within clinical and public health practice promises to maximize the impact of pathogen genomics for AMR globally in the coming decade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GenomicsAnti-Bacterial AgentsDrug Resistance, BacterialBacteriaHumansGenome, BacterialWhole Genome Sequencing

Stichwörter der Autor:innen

antimicrobial resistancegenomics

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • WHO Collaborating Centre for Antimicrobial Resistance, Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia.
  • Centre for Pathogen Genomics, University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Microbiology and Immunology, University of Melbourne at the Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Department of Infectious Diseases, Monash Health, Clayton, Victoria, Australia.

ORCID-Profile: Norelle L Sherry, Jean Y H Lee, Stefano G Giulieri, Adrian Egli, Timothy P Stinear, Benjamin P Howden

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Sherry, N. L., Lee, J. Y. H., Giulieri, S. G., Connor, C. H., Horan, K., Lacey, J. A., Lane, C. R., Carter, G. P., Seemann, T., Egli, A., Stinear, T. P., & Howden, B. P. (2025). Genomics for antimicrobial resistance—progress and future directions. Antimicrobial Agents and Chemotherapy, 69(5). https://doi.org/10.1128/aac.01082-24

Vancouver

Sherry NL, Lee JYH, Giulieri SG, Connor CH, Horan K, Lacey JA, et al. Genomics for antimicrobial resistance—progress and future directions. Antimicrobial Agents and Chemotherapy. 2025;69(5). doi:10.1128/aac.01082-24

BibTeX
@article{Sherry2025,
  author = {Sherry, Norelle L and Lee, Jean Y H and Giulieri, Stefano G and Connor, Christopher H and Horan, Kristy and Lacey, Jake A and Lane, Courtney R and Carter, Glen P and Seemann, Torsten and Egli, Adrian and Stinear, Timothy P and Howden, Benjamin P},
  title = {Genomics for antimicrobial resistance—progress and future directions},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  volume = {69},
  number = {5},
  doi = {10.1128/aac.01082-24}
}
Kostenlos starten →